TempSure
DeviceRadiofrequency platform
NCT Number: NCT05166824
The purpose of this study was to develop parameters and assess the safety of the radiofrequency device for a variety of treatments. Treatment results were also evaluated.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Cynosure, Westford, Massachusetts, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Radiofrequency platform
Cold knife
Electrosurgery and electrocautery platform
Radiofrequency platform
Time frame: 30 days post final treatment
The subject will be asked their level of satisfaction using a 6-point Likert scale that ranges from "extremely satisfied" to "extremely unsatisfied," with 1 being extremely unsatisfied and 6 being extremely satisfied.
Time frame: Immediately Post Treatment (Same Day)
This is the number of tissue samples removed by the device (on 1 subject) that has similar histological results to scalpels and cautery devices currently on the market.
Cynosure, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06415760
Cardiovascular Diseases, Coagulation
Gainesville, Florida, United States
View Trial DetailsNCT04746391
Cardiovascular Diseases, Coagulation
Ghent, Belgium
View Trial DetailsNCT04744688
Abdominal Neoplasms, Bleeding
Aarhus, Aarhus N, Denmark
View Trial DetailsNCT03255187
Blood Pressure, Cardiovascular Diseases
Shanghai, Shanghai Municipality, China
View Trial Details